Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Biomarin Pharmaceutical Inc (NASDAQ:BMRN)

86.92
Delayed Data
As of Jan 13
 +0.76 / +0.88%
Today’s Change
62.12
Today|||52-Week Range
102.49
+4.93%
Year-to-Date

Today’s Trading

Previous close86.16
Today’s open86.16
Day’s range85.91 - 88.13
Volume1,037,735
Average volume (3 months)1,268,581
Market cap$14.9B
Dividend yield--
Data as of 4:00pm ET, 01/13/2017

Growth & Valuation

Earnings growth (last year)-16.30%
Earnings growth (this year)-246.63%
Earnings growth (next 5 years)+26.50%
Revenue growth (last year)+16.29%
P/E ratioNM
Price/Sales19.22
Price/Book5.85

Competitors

 Today’s
change
Today’s
% change
PRGOPerrigo Company PLC-0.38-0.49%
MYLMylan NV-0.04-0.11%
VRTXVertex Pharmaceutica...+0.78+0.95%
ALKSAlkermes Plc+0.81+1.48%
Data as of 4:02pm ET, 01/13/2017

Financials

Next reporting dateFebruary 23, 2017
EPS forecast (this quarter)-$0.38
Annual revenue (last year)$872.2M
Annual profit (last year)-$171.8M
Net profit margin-19.70%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Jean-Jacques Bienaimé
Chief Financial Officer &
Executive Vice President
Daniel K. Spiegelman
Corporate headquarters
San Rafael, California

Forecasts


Search for Jobs